ADVERTISEMENT
  About the SA Blog Network













Observations

Observations


Opinion, arguments & analyses from the editors of Scientific American
Observations HomeAboutContact

Prion evolution takes lessons on diversification from viruses

The views expressed are those of the author and are not necessarily those of Scientific American.


Email   PrintPrint



When prions are transferred from one species to another—like from sheep and cows to mice in the laboratory or to humans in the case of the fatally neurodegenerative variant Creutzfeldt-Jakob disease—new forms of the infectious proteins can emerge over time that make them deadly to the new host. A new study examines the emergence and persistence of prion mutations, which allow prions to grow in infected cells in the presence of anti-prion compounds.

In the classic sense, prions, which are misfolded versions of the brain protein PrP, cannot mutate because they do not contain DNA or RNA. They can, however, give rise to variants with different properties, possibly due to differences in the folding, or shape, of the proteins. In the study, published December 31 in Science Express, researchers estimated the rate at which prion mutants can appear in cultured human nerve cells. In addition, the study suggests that once variants appear, they persist at low levels, giving rise to a heterogeneous prion population.

"On the face of it, you have exactly the same process of mutation and adaptive change in prions as you see in viruses," said Dr. Charles Weissmann in a prepared statement. Weissmann, who is the head of the Scripps Florida Department of Infectology in Jupiter, Fla., led the study.

To track prion mutation, Weissmann’s team mixed one prion-infected human nerve cell with 1,000 uninfected human nerve cells in each petri dish. The infected cell contained a single prion that was susceptible to a drug called swainsonine, or swa. Then the team let the cells grow in the presence of swa. Because the team knew that each dish started with a single, swa-sensitive prion, the researchers knew that any additional prion-positive cells would mean that swa-resistant strains had developed that got released from the infected cells and spread to other cells in the dish. Based on the number of times the cells divided and the number of prion-positive cells in the dish, the group could roughly estimate how quickly prions became swa-resistant.

The researchers began to see new prion-infected cells after leaving the swa-sensitive prion in the drug for 22 cell divisions, which took about 22 days. In other petri dishes, drug resistant strains did not emerge until the cells had doubled over 50 times, or for 50 days. From these results, Weissmann’s team approximated that one swa-resistant prion will emerge for every one million new prions that are formed.

The researchers pointed out that traits other than swa-resistance could be selected for in a population, and that the mutation rate they estimated only reflects new prion strains that acquired swa-resistance. "The overall mutation rate could be even greater and the prion population more diverse, comprising a multiplicity of ‘substrains,’" the authors wrote.

Weissmann and his collaborators found that, similar to how viruses respond after antiviral drug treatment is stopped, prions reacquire drug susceptibility in the absence of swa. When the researchers removed swa from the medium in which prion-infected cells were grown, they found that the cells began to secrete swa-sensitive, instead of swa-resistant strains, after the cells had divided about 10 times. It is unclear if these susceptible variants came from newly formed prions or if they had been present in low levels during cell growth in swa medium. Nonetheless, even after about a month of growing cells in the absence of swa, the group found that 0.5 percent of prions remained drug resistant, indicating that this resistant variant could persist as a minority species in the population.

The fact that new prion "substrains" can appear and spread among cells in just a couple dozen cell divisions suggests that drug-resistance could easily develop in the lifetime of the host, from mouse to man. As a result, therapeutic attempts to inhibit the prion form of PrP are "likely to be thwarted," the authors wrote. A more promising approach, they suggest, would be to stabilize or reduce the expression of the normal form of PrP. Earlier studies by Weissmann and his collaborators showed that mice genetically engineered to lack the PrP gene were healthy, suggesting that the protein is not essential, at least for these animals. Different groups are pursuing the possibility of silencing the PrP gene or using antibodies that bind normal PrP protein as a treatment for prion disease.

Image of brain tissue showing neuron loss from variant Creutzfeldt-Jakob disease courtesy of  the CDC





Rights & Permissions

Comments 5 Comments

Add Comment
  1. 1. coolmoss 2:04 pm 01/1/2010

    A very interesting discovery. There is no reason why natural selection wouldn’t operate on a more rudimentary level. Primitive replicators would be subject to the same selective pressures that any more complex cellular polymer would be beholden to.
    But I’m sure that I had read somewhere in a skinny orange booklet that Darwinian evolution requires complex life in order for natural selection to take place. How can this be? Couldn’t I have been lied to by someone in a position of trust? Could someone pass on bogus information only to preserve thier beliefs?

    Link to this
  2. 2. coolmoss 2:06 pm 01/1/2010

    I know. I can be such a shit sometime.
    Gotta love those simple replicators.

    Link to this
  3. 3. Ralf123 3:36 am 01/11/2010

    You can demonstrate Darwinian evolution in anything that is subject to variation (mutation) and selection. Anything from numbers to viruses to humans. Some cosmologists say maybe even universes. I like that hypothesis.

    Link to this
  4. 4. cerniagigante 4:08 am 01/11/2010

    Abstract evolutionary biology is just a branch of informatics, which is just a branch of mathematics.

    Applied scientists must preoccupy themselves with the details and the biochemical processes that make evolution arise.

    The article hints that there is no mutation if no RNA/DNA is involved; I don’t understand you can be sure that no other process could lead to mutation (and thus selection).

    In fact, I can program "life" (not the classic, but a more sophisticated version, including many forms of life that prey on each other and mutate) on my laptop…

    Link to this
  5. 5. cerniagigante 4:17 am 01/11/2010

    Some very smart people were preoccupied that the LHC will produce a black hole that will swallow all earth in it. Failing to notice the funny side of this story they decided to sue CERN.

    However, there is much more reason for concern when scientists playing with prions and manually manufacturing more resistant culivars (sorry, in want of better term, I use this agricultural equivalent of what the scientists are doing).

    After all, the likelihood of a black hole being created is practically null (in fact, the only black hole created so far in Geneva is one that swallows taxpayer’s cash) and, in the event this happened, the earth would collapse so quickly we wouldn’t even have time to notice (who will get the compensation from lawsuit that those smarties initiated).

    On the other hand, if a prion epidemic such as mad cow, albeit more virulent (or is it priolent?) ensued it would leave the lawsuit followers enough time to cash in.

    Link to this

Add a Comment
You must sign in or register as a ScientificAmerican.com member to submit a comment.

More from Scientific American

Scientific American Holiday Sale

Give a Gift &
Get a Gift - Free!

Give a 1 year subscription as low as $14.99

Subscribe Now! >

X

Email this Article

X